Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 15.25% is in line with its 5-year average of 13.92%, around the middle of its 5-year range (8.22%–26.78%).
0.91% below its 12-month average of 15.39%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 16.15%.
OPERATING MARGIN
15.25%
OPERATING MARGIN AVG TTM
15.39%
OPERATING MARGIN AVG 3Y
15.71%
OPERATING MARGIN AVG 5Y
13.92%
OPERATING MARGIN AVG 10Y
11.92%
OPERATING MARGIN AVG 15Y
11.43%
OPERATING MARGIN AVG 20Y
10.67%
CURRENT VS TTM AVG
-0.91%
CURRENT VS 3Y AVG
-2.91%
CURRENT VS 5Y AVG
+9.54%
CURRENT VS 10Y AVG
+27.99%
CURRENT VS 15Y AVG
+33.38%
CURRENT VS 20Y AVG
+42.86%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
UFP Technologies, Inc.
Market Cap
$2.33B
Operating Margin
15.25%
TTM Avg
15.39%
3Y Avg
15.71%
5Y Avg
13.92%
Market Cap
$2.34B
Operating Margin
-340.16%
TTM Avg
-365.34%
3Y Avg
-352.03%
5Y Avg
-361.50%
Market Cap
$2.34B
Operating Margin
42.26%
TTM Avg
35.06%
3Y Avg
13.24%
5Y Avg
-28.82%
Market Cap
$2.31B
Operating Margin
-32.45%
TTM Avg
-449.54%
3Y Avg
-390.50%
5Y Avg
-1635.66%
Market Cap
$2.28B
Operating Margin
24.03%
TTM Avg
25.35%
3Y Avg
27.79%
5Y Avg
25.07%
Market Cap
$2.38B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.41B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.41B
Operating Margin
-0.74%
TTM Avg
-3.89%
3Y Avg
-12.55%
5Y Avg
-17.88%
Market Cap
$2.22B
Operating Margin
-42.22%
TTM Avg
-21.11%
3Y Avg
-21.11%
5Y Avg
-21.11%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| UFP Technologies, Inc. (UFPT) | $2.33B | 15.25% | 15.39% | 15.71% | 13.92% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.34B | -340.16% | -365.34% | -352.03% | -361.50% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 42.26% | 35.06% | 13.24% | -28.82% |
| Liquidia Corporation (LQDA)vs › | $2.31B | -32.45% | -449.54% | -390.50% | -1635.66% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 24.03% | 25.35% | 27.79% | 25.07% |
| Disc Medicine, Inc. (IRON)vs › | $2.38B | 0.00% | 0.00% | 0.00% | 0.00% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.41B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.41B | -0.74% | -3.89% | -12.55% | -17.88% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.22B | -42.22% | -21.11% | -21.11% | -21.11% |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.47B | -5.13% | 3.60% | 3.31% | 10.24% |
Gross Margin
28.5%
Operating Margin
15.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 16.15% |
| 2026-03-31 | 15.14% |
| 2025-12-31 | 14.44% |
| 2025-09-30 | 15.13% |
| 2025-06-30 | 16.09% |
| 2025-03-31 | 15.61% |
| 2024-12-31 | 15.45% |
| 2024-09-30 | 17.06% |
| 2024-06-30 | 16.29% |
| 2024-03-31 | 15.16% |
| 2023-12-31 | 12.55% |
| 2023-09-30 | 14.93% |
| 2023-06-30 | 17.04% |
| 2023-03-31 | 13.14% |
| 2022-12-31 | 11.92% |
| 2022-09-30 | 26.78% |
| 2022-06-30 | 12.93% |
| 2022-03-31 | 8.93% |
| 2021-12-31 | 8.22% |
| 2021-09-30 | 10.01% |
| 2021-06-30 | 12.25% |
| 2021-03-31 | 10.91% |
| 2020-12-31 | 10.93% |
| 2020-09-30 | 8.60% |
| 2020-06-30 | 7.02% |
| 2020-03-31 | 10.51% |
| 2019-12-31 | 13.42% |
| 2019-09-30 | 12.43% |
| 2019-06-30 | 12.79% |
| 2019-03-31 | 11.10% |
| 2018-12-31 | 10.84% |
| 2018-09-30 | 12.31% |
| 2018-06-30 | 11.56% |
| 2018-03-31 | 5.97% |
| 2017-12-31 | 5.53% |
| 2017-09-30 | 7.01% |
| 2017-06-30 | 10.37% |
| 2017-03-31 | 8.65% |
| 2016-12-31 | 6.19% |
| 2016-09-30 | 10.96% |
| 2016-06-30 | 11.06% |
| 2016-03-31 | 4.94% |
| 2015-12-31 | 7.67% |
| 2015-09-30 | 8.87% |
| 2015-06-30 | 9.55% |
| 2015-03-31 | 7.56% |
| 2014-12-31 | 7.04% |
| 2014-09-30 | 8.75% |
| 2014-06-30 | 8.19% |
| 2014-03-31 | 9.23% |
| 2013-12-31 | 15.22% |
| 2013-09-30 | 12.92% |
| 2013-06-30 | 12.93% |
| 2013-03-31 | 8.77% |
| 2012-12-31 | 13.79% |
| 2012-09-30 | 12.73% |
| 2012-06-30 | 12.79% |
| 2012-03-31 | 11.54% |
| 2011-12-31 | 13.41% |
| 2011-09-30 | 10.61% |
| 2011-06-30 | 12.89% |
| 2011-03-31 | 12.41% |
| 2010-12-31 | 14.13% |
| 2010-09-30 | 12.48% |
| 2010-06-30 | 12.22% |
| 2010-03-31 | 8.52% |
| 2009-12-31 | 14.77% |
| 2009-09-30 | 8.63% |
| 2009-06-30 | 4.56% |
| 2009-03-31 | 2.93% |
| 2008-12-31 | 6.70% |
| 2008-09-30 | 7.52% |
| 2008-06-30 | 9.29% |
| 2008-03-31 | 7.02% |
| 2007-12-31 | 11.72% |
| 2007-09-30 | 6.76% |
| 2007-06-30 | 7.45% |
| 2007-03-31 | 4.48% |
| 2006-12-31 | 6.56% |
| 2006-09-30 | 4.06% |
| 2006-06-30 | 5.78% |
| 2006-03-31 | 5.06% |
| 2005-12-31 | 3.56% |
| 2005-09-30 | 0.09% |
| 2005-06-30 | 3.60% |
| 2005-03-31 | 3.15% |
| 2004-12-31 | 4.58% |
| 2004-09-30 | 2.88% |
| 2004-06-30 | 3.23% |
| 2004-03-31 | 1.64% |
| 2003-12-31 | -9.36% |
| 2003-09-30 | 1.53% |
| 2003-06-30 | 0.64% |
| 2003-03-31 | -2.99% |
| 2002-12-31 | 1.36% |
| 2002-09-30 | 1.34% |
